Total Funding
58
58
Total FundingSeries C raised
Growth Score
-2 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
25764
InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact.
James Mc Leod: EVP & US Chief Medical Officer- Francis Cao: Co-Founder & COO
About the Company
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equipped
with global-level top-notch know-how and efficient execution capabilities.
